Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent Disease

https://doi.org/10.1016/S0003-4975(10)62281-3Get rights and content

Abstract

Three hundred forty-six patients with postsurgical non-small cell Stage I bronchogenic carcinoma were followed from 5.0 to 10.8 years (median, 7.0 years). Recurrent cancer developed in 135 patients (39%). Seventy-five recurrences were nonregional metastases (55.6%); 35 (25.9%), a subsequent primary lung cancer; and 25 (18.5%), local recurrence only. The rate of recurrent lung cancer decreased from 15.0 patients per 100 patient-years the first postoperative year to 2.3 the seventh and subsequent years. The rate of recurrence varied among the three different types of recurrent cancer. Five years after pulmonary resection, 70.0% of patients with T1 N0 neoplasms had no evidence of recurrence compared with 58.2% of patients with T2 N0 tumors (p = 0.012) and only 31.8% of patients with T1 N1 neoplasms (p < 0.001). There was no significant difference in overall rate of recurrence among the various cell types. Currently, 174 patients are alive. Lung cancer survival (Kaplan-Meier) was 69.1% at 5 years and 61.9% at 9 years. At 2 years following detection of subsequent lung cancer, 51.8% of patients with subsequent primary lung cancer had survived lung cancer compared with 23.4% for those with local recurrence and only 8.9% for those with nonregional metastases.

References (11)

There are more references available in the full text version of this article.

Cited by (327)

View all citing articles on Scopus

Presented at the Twentieth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 23–25, 1984.

Supported in part by Research Grant N0 1-CN-53886 from the National Institutes of Health, Public Health Service.

The authors thank William F. Taylor, Ph.D., Mrs. Maryann Uhlenhopp, Mrs. Eunice Bergstrom, Miss Nancy Neumann, and Robert S. Fontana, M.D., for their invaluable suggestions and assistance in obtaining follow-up information on these patients.

View full text